These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27692547)

  • 1. Synthesis and activity of newly designed aroxyalkyl or aroxyethoxyethyl derivatives of piperazine on the cardiovascular and the central nervous systems.
    Waszkielewicz AM; Kubacka M; Pańczyk K; Mogilski S; Siwek A; Głuch-Lutwin M; Gryboś A; Filipek B
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5315-5321. PubMed ID: 27692547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and activity of di- or trisubstituted N-(phenoxyalkyl)- or N-{2-[2-(phenoxy)ethoxy]ethyl}piperazine derivatives on the central nervous system.
    Pańczyk K; Pytka K; Jakubczyk M; Rapacz A; Sałat K; Furgała A; Siwek A; Głuch-Lutwin M; Gryboś A; Słoczyńska K; Pękala E; Żmudzki P; Bucki A; Kołaczkowski M; Żelaszczyk D; Marona H; Waszkielewicz AM
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2039-2049. PubMed ID: 29730027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like activity of aroxyalkyl derivatives of 2-methoxyphenylpiperazine and evidence for the involvement of serotonin receptor subtypes in their mechanism of action.
    Kubacka M; Mogilski S; Bednarski M; Nowiński L; Dudek M; Żmudzka E; Siwek A; Waszkielewicz AM; Marona H; Satała G; Bojarski A; Filipek B; Pytka K
    Pharmacol Biochem Behav; 2016 Feb; 141():28-41. PubMed ID: 26647362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic, hypotensive and α1-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone.
    Rapacz A; Pytka K; Sapa J; Kubacka M; Filipek B; Szkaradek N; Marona H
    Eur J Pharmacol; 2014 Jul; 735():10-6. PubMed ID: 24751714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, alpha-adrenoceptors affinity and alpha 1-adrenoceptor antagonistic properties of some 1,4-substituted piperazine derivatives.
    Marona H; Kubacka M; Filipek B; Siwek A; Dybała M; Szneler E; Pociecha T; Gunia A; Waszkielewicz AM
    Pharmazie; 2011 Oct; 66(10):733-9. PubMed ID: 22026152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of antidepressant-like activity of some 4-substituted 1-(2-methoxyphenyl)piperazine derivatives.
    Waszkielewicz AM; Pytka K; Rapacz A; Wełna E; Jarzyna M; Satała G; Bojarski A; Sapa J; Żmudzki P; Filipek B; Marona H
    Chem Biol Drug Des; 2015 Mar; 85(3):326-35. PubMed ID: 25048712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Design, synthesis and vasorelaxant activity of R, S-1-(substituted phenyl)-4-[3-(naphtha-1-yl-oxy)-2-hydroxypropyl]-piperazine derivatives].
    Fu XZ; Tang L; Yuan M; Shi JS
    Yao Xue Xue Bao; 2007 Jul; 42(7):735-40. PubMed ID: 17882957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
    Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
    Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine.
    Kubacka M; Mogilski S; Filipek B; Marona H
    Eur J Pharmacol; 2013 Jan; 698(1-3):335-44. PubMed ID: 23117089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like activity of the phenylpiperazine pyrrolidin-2-one derivatives in mice.
    Sapa J; Filipek B; Kulig K; Malawska B
    Pharmacol Rep; 2011; 63(1):71-8. PubMed ID: 21441613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual NK(1) antagonists--serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives.
    Ryckmans T; Berton O; Grimée R; Kogej T; Lamberty Y; Pasau P; Talaga P; Genicot C
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3195-8. PubMed ID: 12372532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1,4-Benzothiazinyloxy)alkylpiperazine derivatives as potential antihypertensive agents.
    Cecchetti V; Schiaffella F; Tabarrini O; Fravolini A
    Bioorg Med Chem Lett; 2000 Mar; 10(5):465-8. PubMed ID: 10743949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of some aroxyethylamine derivatives for hypotensive properties and their affinities for adrenergic receptors.
    Maciag D; Filipek B; Czekaj T; Marona H; Nowak G
    Pharmazie; 2003 Dec; 58(12):899-905. PubMed ID: 14703970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of new piperazine-pyridazinone derivatives and their binding affinity toward alpha1-, alpha2-adrenergic and 5-HT1A serotoninergic receptors.
    Betti L; Zanelli M; Giannaccini G; Manetti F; Schenone S; Strappaghetti G
    Bioorg Med Chem; 2006 Apr; 14(8):2828-36. PubMed ID: 16376083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBK-7 - A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties.
    Pytka K; Kazek G; Siwek A; Mordyl B; Głuch-Lutwin M; Rapacz A; Olczyk A; Gałuszka A; Waszkielewicz A; Marona H; Sapa J; Filipek B; Zygmunt M
    Pharmacol Biochem Behav; 2016; 146-147():35-43. PubMed ID: 27132236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
    Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
    Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological analysis of the hypothermic effects of NAN-190 and its analogs, postsynaptic 5-HT1A receptor antagonists, in mice.
    Wesołowska A; Borycz J; Paluchowska MH; Chojnacka-Wójcik E
    Pol J Pharmacol; 2002; 54(4):391-9. PubMed ID: 12523493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
    Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
    Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P; Marciniec K; Maślankiewicz A; Satała G; Duszyńska B; Bojarski AJ; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Pawłowski M
    Bioorg Med Chem; 2012 Feb; 20(4):1545-56. PubMed ID: 22277589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.